RBC Bioscience Corporation (TPEX:6848)
19.15
-0.45 (-2.30%)
At close: Apr 24, 2026
RBC Bioscience Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 36.44 | 79.86 | 65.18 | 75.93 | 97.47 |
Cash & Short-Term Investments | 36.44 | 79.86 | 65.18 | 75.93 | 97.47 |
Cash Growth | -54.37% | 22.53% | -14.16% | -22.10% | -21.36% |
Accounts Receivable | 26.21 | 13.49 | 23 | 25.59 | 24.68 |
Other Receivables | 1.02 | 1.27 | 0.7 | 0.71 | 1.33 |
Receivables | 27.23 | 14.76 | 23.7 | 26.3 | 26.01 |
Inventory | 47.49 | 52.76 | 44.42 | 47.2 | 51.2 |
Other Current Assets | 9.1 | 9.43 | 6.91 | 7.47 | 33.95 |
Total Current Assets | 120.26 | 156.8 | 140.21 | 156.9 | 208.62 |
Property, Plant & Equipment | 508.55 | 520.97 | 533.54 | 556.74 | 621.22 |
Other Intangible Assets | 17.18 | 12.87 | 3.14 | 2.45 | 3.17 |
Long-Term Deferred Tax Assets | 3.18 | 3.53 | 3.26 | 3.41 | 4.09 |
Other Long-Term Assets | 75.33 | 69.71 | 73.63 | 71.05 | 10.51 |
Total Assets | 724.49 | 763.88 | 753.79 | 790.55 | 847.6 |
Accounts Payable | 24.07 | 23.77 | 15.72 | 22.71 | 35.75 |
Accrued Expenses | - | 13.04 | - | - | - |
Short-Term Debt | - | 25 | 35 | 40 | 64.65 |
Current Portion of Long-Term Debt | 33.34 | 27.92 | 23.03 | 22.69 | 2.11 |
Current Portion of Leases | 1.01 | 1.13 | 1.02 | 1.77 | 1.98 |
Current Income Taxes Payable | 5.13 | 4.92 | 1.26 | 8.51 | 8.05 |
Current Unearned Revenue | 0.71 | 0.92 | 0.31 | 0.26 | 1.34 |
Other Current Liabilities | 31.95 | 14.91 | 23.43 | 27.8 | 34.2 |
Total Current Liabilities | 96.2 | 111.6 | 99.77 | 123.74 | 148.07 |
Long-Term Debt | 356.37 | 399.8 | 412.33 | 416.63 | 439.82 |
Long-Term Leases | 0.46 | 0.85 | 0.27 | 0.66 | 2.43 |
Long-Term Unearned Revenue | 0.94 | 0.61 | 0.43 | 0.43 | 0.45 |
Pension & Post-Retirement Benefits | 1.7 | 1.44 | - | - | - |
Other Long-Term Liabilities | 0.29 | 0.29 | 0.29 | 0.29 | - |
Total Liabilities | 455.96 | 514.58 | 513.08 | 541.73 | 590.77 |
Common Stock | 142.73 | 129.76 | 129.76 | 129.76 | 117.96 |
Additional Paid-In Capital | - | 50.45 | 50.45 | 50.45 | 50.45 |
Retained Earnings | 75.36 | 69.09 | 60.5 | 68.61 | 88.42 |
Comprehensive Income & Other | 50.45 | - | - | - | - |
Shareholders' Equity | 268.54 | 249.3 | 240.71 | 248.81 | 256.83 |
Total Liabilities & Equity | 724.49 | 763.88 | 753.79 | 790.55 | 847.6 |
Total Debt | 391.17 | 454.7 | 471.65 | 481.75 | 510.99 |
Net Cash (Debt) | -354.73 | -374.84 | -406.47 | -405.82 | -413.52 |
Net Cash Per Share | -24.71 | -26.09 | -28.42 | -28.35 | -30.57 |
Filing Date Shares Outstanding | 14.26 | 14.27 | 14.27 | 14.27 | 14.27 |
Total Common Shares Outstanding | 14.26 | 14.27 | 14.27 | 14.27 | 14.27 |
Working Capital | 24.06 | 45.2 | 40.45 | 33.16 | 60.55 |
Book Value Per Share | 18.83 | 17.47 | 16.86 | 17.43 | 17.99 |
Tangible Book Value | 251.36 | 236.43 | 237.57 | 246.36 | 253.66 |
Tangible Book Value Per Share | 17.62 | 16.56 | 16.64 | 17.26 | 17.77 |
Land | - | 354.26 | 354.26 | 354.26 | 401.43 |
Buildings | - | 170.11 | 170.11 | 183.13 | 193.16 |
Machinery | - | 76.3 | 75.96 | 69.14 | 60.79 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.